Loading clinical trials...
Loading clinical trials...
This is a noninterventional registry-based cohort study utilizing data collected on danicopan-treated patients with paroxysmal nocturnal hemoglobinuria (PNH) through the International PNH Interest Gro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alexion Pharmaceuticals, Inc.
NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more
NCT05876312 · Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT04645199 · Multiple Myeloma, Acute Myeloid Leukemia, and more
NCT06449001 · Paroxysmal Nocturnal Hemoglobinuria, PNH, and more
Clinical Research Site
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions